<?xml version="1.0" encoding="UTF-8"?>
<p id="Par48">Genotypic resistance testing is usually performed on the reverse transcriptase and protease genes of HIV and it is performed in case of suboptimal viral reduction and to assist in the selection of active drugs. Mutations that lead to high-level reduced susceptibility to integrase inhibitors have been described. Pre-treatment resistance testing is advised, due to the risk of transmission of resistant virus strains.</p>
